| SPARK: A US cohort of 50,000 families to accelerate autism research P Feliciano, AM Daniels, LAG Snyder, A Beaumont, A Camba, A Esler, ... Neuron 97 (3), 488-493, 2018 | 396 | 2018 |
| Aggression in autism spectrum disorder: presentation and treatment options SE Fitzpatrick, L Srivorakiat, LK Wink, EV Pedapati, CA Erickson Neuropsychiatric disease and treatment, 1525-1538, 2016 | 355 | 2016 |
| Gastrointestinal symptoms in a sample of children with pervasive developmental disorders RN Nikolov, KE Bearss, J Lettinga, C Erickson, M Rodowski, MG Aman, ... Journal of autism and developmental disorders 39, 405-413, 2009 | 325 | 2009 |
| Gastrointestinal factors in autistic disorder: a critical review CA Erickson, KA Stigler, MR Corkins, DJ Posey, JF Fitzgerald, ... Journal of autism and developmental disorders 35, 713-727, 2005 | 265 | 2005 |
| Antipsychotics in the treatment of autism DJ Posey, KA Stigler, CA Erickson, CJ McDougle The Journal of clinical investigation 118 (1), 6-14, 2008 | 258 | 2008 |
| Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes P Feliciano, X Zhou, I Astrovskaya, TN Turner, T Wang, L Brueggeman, ... NPJ genomic medicine 4 (1), 19, 2019 | 227 | 2019 |
| Diagnosing autism spectrum disorder from brain resting-state functional connectivity patterns using a deep neural network with a novel feature selection method X Guo, KC Dominick, AA Minai, H Li, CA Erickson, LJ Lu Frontiers in neuroscience 11, 460, 2017 | 215 | 2017 |
| A retrospective study of memantine in children and adolescents with pervasive developmental disorders CA Erickson, DJ Posey, KA Stigler, J Mullett, AR Katschke, CJ McDougle Psychopharmacology 191, 141-147, 2007 | 194 | 2007 |
| Neurochemistry in the pathophysiology of autism CJ McDougle, CA Erickson, KA Stigler, DJ Posey Journal of Clinical Psychiatry 66, 9, 2005 | 166 | 2005 |
| Impaired perceptual learning in a mouse model of Fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversible A Goel, DA Cantu, J Guilfoyle, GR Chaudhari, A Newadkar, B Todisco, ... Nature neuroscience 21 (10), 1404-1411, 2018 | 153 | 2018 |
| STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study CA Erickson, JM Veenstra-Vanderweele, RD Melmed, JT McCracken, ... Journal of autism and developmental disorders 44, 958-964, 2014 | 150 | 2014 |
| Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders CJ McDougle, KA Stigler, CA Erickson, DJ Posey Journal of Clinical Psychiatry 69, 15, 2008 | 150 | 2008 |
| Updated report on tools to measure outcomes of clinical trials in fragile X syndrome DB Budimirovic, E Berry-Kravis, CA Erickson, SS Hall, D Hessl, AL Reiss, ... Journal of Neurodevelopmental Disorders 9, 1-36, 2017 | 147 | 2017 |
| A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome J Wang, LE Ethridge, MW Mosconi, SP White, DK Binder, EV Pedapati, ... Journal of neurodevelopmental disorders 9, 1-12, 2017 | 146 | 2017 |
| Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndrome LE Ethridge, SP White, MW Mosconi, J Wang, EV Pedapati, CA Erickson, ... Molecular Autism 8, 1-11, 2017 | 142 | 2017 |
| Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study BA Adler, LK Wink, M Early, R Shaffer, N Minshawi, CJ McDougle, ... Autism 19 (1), 102-106, 2015 | 130 | 2015 |
| Fragile X targeted pharmacotherapy: lessons learned and future directions CA Erickson, MH Davenport, TL Schaefer, LK Wink, EV Pedapati, ... Journal of neurodevelopmental disorders 9, 1-14, 2017 | 129 | 2017 |
| A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder LK Wink, R Adams, Z Wang, JE Klaunig, MH Plawecki, DJ Posey, ... Molecular autism 7, 1-9, 2016 | 128 | 2016 |
| Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study KA Stigler, JT Diener, AE Kohn, L Li, CA Erickson, DJ Posey, ... Journal of Child and Adolescent Psychopharmacology 19 (3), 265-274, 2009 | 118 | 2009 |
| Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome CA Erickson, LK Wink, B Ray, MC Early, E Stiegelmeyer, ... Psychopharmacology 228, 75-84, 2013 | 115 | 2013 |
